Published in Am J Respir Crit Care Med on November 01, 1998
The relationship between the sibling recurrence-risk ratio and genotype relative risk. Am J Hum Genet (2000) 1.34
Sarcoidosis vs. Sarcoid-like reactions: The Two Sides of the same Coin? Wien Med Wochenschr (2014) 1.05
Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy. Ann Surg (2005) 0.92
Clinically isolated laryngeal sarcoidosis. Eur Arch Otorhinolaryngol (2010) 0.87
Surfactant gene polymorphisms and interstitial lung diseases. Respir Res (2001) 0.87
Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc (2007) 0.82
Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res (2001) 0.81
Genetic predisposition to respiratory diseases: infiltrative lung diseases. Respiration (2007) 0.79
Association between I/D polymorphism in the ACE gene and sarcoidosis in Turkish patients. Cytotechnology (2014) 0.77
Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease. Ophthalmic Epidemiol (2010) 0.76
Elevated aminotransaminases as the first manifestation of sarcoidosis. Case Rep Med (2009) 0.75
Insertion/Deletion Polymorphisms and Serum Angiotensin-converting Enzyme Levels in Iranian Patients with Sarcoidosis. Iran J Public Health (2016) 0.75
The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings. Arch Med Sci (2015) 0.75
Identification of the cystic fibrosis gene: chromosome walking and jumping. Science (1989) 21.46
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol (1997) 5.00
Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science (1987) 3.87
The clinical course of pulmonary embolism. N Engl J Med (1992) 3.70
A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med (1997) 2.76
Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med (1998) 2.43
The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology (1998) 2.32
Need for vaccination of sewer workers against leptospirosis and hepatitis A. Occup Environ Med (1995) 2.02
Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology (1999) 1.95
The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol (2000) 1.90
Smoking and Parkinson's disease: a dose-response relationship. Neurology (1999) 1.86
Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest (1996) 1.79
Occupational exposures to metals as risk factors for Parkinson's disease. Neurology (1997) 1.78
Acute normovolemic hemodilution combined with hypotensive anesthesia and other techniques to avoid homologous transfusion in spinal fusion surgery. Spine (Phila Pa 1976) (1992) 1.69
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med (2001) 1.68
A cystic fibrosis pancreatic adenocarcinoma cell line. Proc Natl Acad Sci U S A (1990) 1.62
Seroepidemiologic study of three zoonoses (leptospirosis, Q fever, and tularemia) among trappers in Québec, Canada. Clin Diagn Lab Immunol (1995) 1.55
Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J (1999) 1.54
The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease. Chest (1992) 1.51
Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology (1999) 1.44
Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect (1998) 1.42
Physical mapping of the cystic fibrosis region by pulsed-field gel electrophoresis. Genomics (1988) 1.38
SacI RFLP in the human von Willebrand factor gene. Nucleic Acids Res (1987) 1.36
Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines. Am J Physiol (1990) 1.35
Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology (1994) 1.29
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry (2012) 1.23
Leptospirosis in raccoons in Quebec: 2 case reports and seroprevalence in a recreational area. Can Vet J (1997) 1.14
Small cell lung cancer. Am Rev Respir Dis (1986) 1.13
Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy. A comparison of central versus peripheral carcinoma. Am Rev Respir Dis (1982) 1.11
Bronchoalveolar lavage neutrophilia in asthmatic and healthy volunteers after controlled exposure to ozone and filtered purified air. Chest (1994) 1.11
Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer (2000) 1.11
Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers. Pharm Res (2000) 1.09
Respiratory physiology in pregnancy. Clin Chest Med (1992) 1.08
Heterogeneity of familial risk in sarcoidosis. Genet Epidemiol (1996) 1.06
Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg (1990) 1.06
Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol (1999) 1.06
Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun (2005) 1.04
The deletion in both common types of hereditary persistence of fetal hemoglobin is approximately 105 kilobases. Blood (1987) 1.02
Approaches to localizing disease genes as applied to cystic fibrosis. Nucleic Acids Res (1990) 0.98
Intraluminal blood clot casts causing obstructive emphysema and recurrent pneumothorax. Crit Care Med (1982) 0.96
Benefits of aerobic exercise after stroke. Sports Med (1996) 0.95
Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: a randomized, double-blind trial. Crit Care Med (1999) 0.95
Occupational categories at risk for Parkinson's disease. Am J Ind Med (2001) 0.94
A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans. Genes Immun (2010) 0.94
Effect of delay on racial differences in thrombolysis for acute myocardial infarction. Am Heart J (2000) 0.91
Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer (1998) 0.91
Genetics of sarcoidosis. Clin Chest Med (1997) 0.91
Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans. Genes Immun (2012) 0.90
Active tuberculosis in the medical intensive care unit: a 15-year retrospective analysis. Crit Care Med (1987) 0.90
Endoscopic findings in sarcoidosis. Characteristics and correlations with radiographic staging and bronchial mucosal biopsy yield. Ann Otol Rhinol Laryngol (1981) 0.90
Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol (2001) 0.90
Sarcoidosis and granuloma genes: a family-based study in African-Americans. Eur Respir J (2004) 0.90
Bioelectrical impedance assessment of nutritional status in critically ill patients. Am J Clin Nutr (1993) 0.88
Silastic prosthesis plombage for right postpneumonectomy syndrome. Ann Thorac Surg (1990) 0.87
An African-American cystic fibrosis patient homozygous for a novel frameshift mutation associated with reduced CFTR mRNA levels. Hum Mutat (1993) 0.87
Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Hum Mutat (1992) 0.87
Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study. Genes Immun (2007) 0.84
Electrocardiographic presentation of blacks with first myocardial infarction does not explain race differences in thrombolysis administration. Am Heart J (2000) 0.84
The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans. Hum Immunol (1999) 0.83
Intermediate care units. Graded care options. Chest (1991) 0.82
Risk perception of prescription drugs: report on a survey in Canada. Can J Public Health (1991) 0.82
Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis. Am J Respir Crit Care Med (1998) 0.82
Expanded gentamicin volume of distribution in patients with indicators of malnutrition. Clin Pharm (1990) 0.82
Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. Am J Respir Crit Care Med (1995) 0.81
Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans. Am J Hematol (1998) 0.81
The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1999) 0.81
Relationship of bioelectrical impedance to pharmacokinetic parameters of theophylline in healthy males. Clin Pharmacokinet (1989) 0.81
HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2008) 0.81
RsaI RFLP in the human von Willebrand factor gene. Nucleic Acids Res (1987) 0.80
Binding of heparin to human high molecular weight kininogen. Biochemistry (1989) 0.80
Treatment of massive acute pulmonary embolism. The use of low doses of intrapulmonary arterial streptokinase combined with full doses of systemic heparin. Chest (1988) 0.80